SimBioSys Launches TumorSight Plan for Enhanced Breast Cancer Surgery Decision Support

SimBioSys®, a leading TechBio company pioneering the fusion of spatial biophysics with artificial intelligence (AI) and computational modeling to redef...

April 10, 2024 | Wednesday | News
Hartwig Medical Foundation and Ultima Genomics Partner to Enhance Cancer Genomic Profiling

-Hartwig Medical Foundation, a pioneer in deploying complete genomic profiling to improve oncology outcomes, and Ultima Genomics, a developer of a revoluti...

April 08, 2024 | Monday | News
UroGen Pharma vs. Teva: Legal Clash Over "Totally Mundane" Cancer Treatment Patents

UroGen Pharma has initiated legal proceedings against pharmaceutical giant Teva over what they're dubbing as "Totally Mundane" Cancer Treatment Patents. Ur...

April 04, 2024 | Thursday | News
Genmab to Acquire ProfoundBio for USD 1.8 Billion in Cash

Genmab A/S (Nasdaq: GMAB) and ProfoundBio, Inc. have officially announced a definitive agreement for Genmab's acquisition of ProfoundBio in an all-cash dea...

April 03, 2024 | Wednesday | News
Maverix Medical Acquires Cirrus Bio to Spearhead Lung Cancer Diagnostics, Establishes Maverix Dx Division

Maverix Medical, a dedicated lung cancer platform established by Ajax Health, KKR, and Hologic, Inc.,  announced the acquisition of Cirrus Bio for an ...

April 01, 2024 | Monday | News
Exact Sciences and Mayo Clinic Report Promising Data on Non-Endoscopic Esophageal Cancer Screening Test

  Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, in collaboration with Mayo Clinic Compr...

March 28, 2024 | Thursday | News
Function Oncology and Volastra Therapeutics Form Strategic Partnership to Enhance Precision Cancer Treatment

-Function Oncology, a company transforming the operating system of precision medicine with CRISPR-powered platform technology, today announced an innovativ...

March 27, 2024 | Wednesday | News
Bayer and Thermo Fisher Scientific Join Forces to Expand Access to Precision Cancer Treatments

    The innovative partnership seeks to revolutionize decentralized genomic testing, offering swift turnaround times to identify individuals wh...

March 21, 2024 | Thursday | News
Australia's Telix Pharmaceuticals Forges Alliance to Drive Personalized Cancer Treatment

Telix Pharmaceuticals Limited (ASX: TLX) has announced a strategic agreement to partner with ABX-CRO Advanced Pharmaceutical Services Forschungsgesellschaf...

March 19, 2024 | Tuesday | News
AstraZeneca's Quantum Leap in Cancer Treatment: Acquires Fusion Pharmaceuticals for Next-Gen Radioconjugates

AstraZeneca has announced its definitive agreement to acquire Fusion Pharmaceuticals Inc., a trailblazing clinical-stage biopharmaceutical company speciali...

March 19, 2024 | Tuesday | News
Clarity Pharmaceuticals Advances Theranostic Prostate Cancer Trial to Multi-Dose Phase

    The completion of Cohort 3 marks a significant milestone, with six participants receiving therapy with 67Cu-SAR-bisPSMA at the highest sing...

March 18, 2024 | Monday | News
Labcorp's Latest Studies at SGO Meeting Herald New Era in Ovarian Cancer Biomarker Testing

In an effort to bridge testing gaps and facilitate targeted therapies for EOC patients, Labcorp conducted two seminal studies, illustrating the profound im...

March 18, 2024 | Monday | News
Fennec and Norgine Partner to Commercialize PEDMARQSI in Europe, Australia, and NZ

Agreement pairs Norgine’s commercial expertise and leading European footprint with PEDMARQSI®, the first and only approved therapy in the Europea...

March 18, 2024 | Monday | News
Novo Holdings Joins €30M Series A Financing for Asgard Therapeutics, Leader in In Vivo Cell Reprogramming to Treat Cancer

Novo Holdings, a leading global life sciences investor, has announced its participation in a significant €30M Series A financing round for Asgard Ther...

March 14, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in